clinical trial · NCT02078427
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
Baxalta now part of Shire·—·completed·n = 951
Hemophilia AADVATEADYNOVI
brief summary
The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice
started
Jun 28, 2011
primary completion
Jan 16, 2024
completion
Jan 16, 2024
last updated
Jun 17, 2024
official title
ADVATE/ ADYNOVI Hemophilia A Outcome Database
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol